Skip to main content
Premium Trial:

Request an Annual Quote

It's Not About Plastics Anymore

Premium

We’ve got one word for you: biochips. According to a new Frost & Sullivan report, the global market for microarrays, microfluidic devices, and other biochips will see annual growth of 65 percent and reach $3.3 billion by 2004.

More than 100 companies have already seen the microarray light, the report says. F&S predicts that segment’s revenues will hit $2.6 billion in 2004, up from estimates of $874 million this year and $232 million in 1999. The report suggests that the microarray market will be marked by ongoing patent disputes, consolidation, a trend toward higher density arrays, and more labs investing in homemade microarrays.

The microfluidics segment, which is said to be just starting, will grow to $395 million by 2004 from $17 million in 1999 and $77 million this year, according to the report. It goes on to note the spurt of alliances emerging between companies in this sector and liquid handling companies.

Other types of chips will grow too, the report says, with estimates at $311 million by 2004, up from $81 million this year. Notable growth is forecast for biochips using bioelectric detection.

Long term, F&S predicts that the sector could eventually see even more growth. “If diagnostic tests (human or otherwise) using biochips become widespread, the market for such products could reach the tens of billions by 2010,” according to the report.

— Marian Moser Jones

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.